Search Media Items

Nanotechnology is a powerful tool for combating cancer. NCI's Alliance for Nanotechnology in Cancer is continuously testing the safety of this new technology.

Information about how the rights and safety of people who take part in clinical trials are protected.

Hoja informativa que resume la evidencia que relaciona el ejercicio y otras actividades físicas, incluso el trabajo y tareas domésticas, para reducir los riesgos de cáncer.

NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.

NCI offers training at laboratories and clinics in Maryland and at universities and institutions nationwide. These cancer training and career development opportunities cover a broad spectrum of disciplines for individuals at career stages ranging from high school and graduate students to scientists, clinicians, and health care professionals.

A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.

Hoja informativa que describe las ventajas y desventajas de varios exámenes selectivos de detección del cáncer colorrectal.

Hoja informativa que define las mamografías de detección y de diagnóstico; trata de los beneficios y perjuicios posibles de las mamografías de detección; y resume cómo se reportan los resultados, incluso la densidad de los senos.

A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for patients with relapsed or refractory disease.

A summary of clinical trial results showing that nivolumab (Opdivo®) improved overall survival compared with standard chemotherapy in patients with head and neck squamous cell carcinoma.